BeyondSpring Inc. (BYSI)
NASDAQ: BYSI
· Real-Time Price · USD
1.81
0.07 (4.02%)
At close: May 01, 2025, 3:58 PM
1.75
-3.31%
After-hours: May 01, 2025, 06:22 PM EDT
4.02% (1D)
| Bid | 1.27 |
| Market Cap | 72.97M |
| Revenue (ttm) | 1.88M |
| Net Income (ttm) | -15.57M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -8.62 |
| Forward PE | 0.88 |
| Analyst | n/a |
| Ask | 1.85 |
| Volume | 29,355 |
| Avg. Volume (20D) | 19,647.4 |
| Open | 1.73 |
| Previous Close | 1.74 |
| Day's Range | 1.63 - 1.84 |
| 52-Week Range | 0.98 - 3.63 |
| Beta | 0.20 |
About BYSI
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combinati...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 9, 2017
Employees 40
Stock Exchange NASDAQ
Ticker Symbol BYSI
